4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0001209191-22-059573
Options or other derivatives
- Chief Operating Officer acquired 462,535 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lecault Veronique Chief Operating Officer | 2022-12-01 | Grant or award · Share Options (right to buy) | +462,535 | 3,392,689 | D | ||
Loading xslF345X03/doc4.xml…